Cubist Systematic Strategies, LLC Rigel Pharmaceuticals Inc Transaction History

Cubist Systematic Strategies, LLC

$15.8 Billion
Q3 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$1.12 - $1.57 $70,711 - $99,121	63,135 New	63,135 $93,000
Q2 2023 Aug 14, 2023	SELL	$1.12 - $1.82 $52,372 - $85,105	-46,761 Reduced 31.6%	101,240 $130,000
Q1 2023 May 15, 2023	SELL	$1.25 - $2.0 $155,588 - $248,942	-124,471 Reduced 45.68%	148,001 $195,000
Q4 2022 Feb 14, 2023	BUY	$0.67 - $11.9 $68,855 - $1.22 Million	102,769 Added 60.56%	272,472 $408,000
Q3 2022 Nov 14, 2022	BUY	$1.1 - $12.2 $104,530 - $1.16 Million	95,028 Added 127.26%	169,703 $200,000
Q2 2022 Aug 15, 2022	BUY	$0.67 - $3.19 $37,774 - $179,852	56,380 Added 308.17%	74,675 $84,000
Q1 2022 May 16, 2022	SELL	$2.22 - $3.45 $6,005 - $9,332	-2,705 Reduced 12.88%	18,295 $55,000
Q4 2021 Feb 14, 2022	BUY	$2.36 - $3.57 $33,955 - $51,365	14,388 Added 217.6%	21,000 $56,000
Q3 2021 Nov 15, 2021	BUY	$3.5 - $4.5 $23,142 - $29,754	6,612 New	6,612 $24,000
Q2 2021 Aug 16, 2021	SELL	$3.09 - $4.54 $111,697 - $164,111	-36,148 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$3.35 - $4.93 $32,417 - $47,707	9,677 Added 36.56%	36,148 $124,000
Q4 2020 Feb 16, 2021	SELL	$2.35 - $3.74 $70,079 - $111,530	-29,821 Reduced 52.98%	26,471 $93,000
Q3 2020 Nov 16, 2020	BUY	$1.78 - $4.13 $100,199 - $232,485	56,292 New	56,292 $135,000
Q4 2019 Feb 14, 2020	SELL	$1.6 - $2.43 $59,508 - $90,378	-37,193 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$1.63 - $2.62 $40,873 - $65,699	25,076 Added 206.95%	37,193 $70,000
Q2 2019 Aug 14, 2019	SELL	$2.02 - $2.61 $124,975 - $161,478	-61,869 Reduced 83.62%	12,117 $32,000
Q1 2019 May 15, 2019	SELL	$2.0 - $2.65 $21,068 - $27,915	-10,534 Reduced 12.46%	73,986 $190,000
Q4 2018 Feb 14, 2019	BUY	$2.08 - $3.36 $131,790 - $212,892	63,361 Added 299.45%	84,520 $194,000
Q3 2018 Nov 14, 2018	SELL	$2.6 - $3.59 $102,440 - $141,446	-39,400 Reduced 65.06%	21,159 $68,000
Q2 2018 Aug 14, 2018	BUY	$2.83 - $4.11 $114,235 - $165,904	40,366 Added 199.9%	60,559 $171,000
Q1 2018 May 15, 2018	BUY	$3.54 - $4.54 $71,483 - $91,676	20,193 New	20,193 $71,000
Q4 2017 Feb 14, 2018	SELL	$3.23 - $4.3 $119,464 - $159,039	-36,986 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$2.18 - $2.57 $80,629 - $95,054	36,986	36,986 $94,000

Others Institutions Holding RIGL

# of Institutions

Shares Held

334K

Call Options Held

Put Options Held

View Full List

About RIGEL PHARMACEUTICALS INC

Ticker RIGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 172,836,000
Market Cap $2.81B
Description
Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is ...

More about RIGL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Account